These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16971235)

  • 1. A five-day gradual reduction regimen of chlormadinone reduces premenstrual anxiety and depression: a pilot study.
    Contreras CM; Azamar-Arizmendi G; Saavedra M; Hernández-Lozano M
    Arch Med Res; 2006 Oct; 37(7):907-13. PubMed ID: 16971235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of kamishoyosan for premenstrual dysphoric disorder: open-labeled pilot study.
    Yamada K; Kanba S
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):323-5. PubMed ID: 17472603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine for premenstrual dysphoric disorder: a pilot study.
    Freeman EW; Rickels K; Sondheimer SJ
    J Clin Psychiatry; 1996; 57 Suppl 8():56-9; discussion 60. PubMed ID: 8698682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of premenstrual depression with nortriptyline: a pilot study.
    Harrison WM; Endicott J; Nee J
    J Clin Psychiatry; 1989 Apr; 50(4):136-9. PubMed ID: 2647713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molindone: a pilot evaluation during the premenstruum.
    Shader RI; Harmatz JS
    Curr Ther Res Clin Exp; 1975 Apr; 17(4):403-6. PubMed ID: 804388
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
    Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
    Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
    Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder.
    Hsiao CC; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):593-9. PubMed ID: 15601382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
    Yonkers KA
    J Clin Psychiatry; 1997; 58 Suppl 3():62-7; discussion 68-9. PubMed ID: 9133494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
    Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
    N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic and therapeutic algorithm for the treatment of premenstrual dysphoric disorder].
    Strkalj Ivezić S; Kusan Jukić M; Tikvica A; Pavicić Baldani D
    Acta Med Croatica; 2010 Jul; 64(3):183-90. PubMed ID: 20922861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month paroxetine treatment of premenstrual dysphoric disorder: continuous versus intermittent treatment protocols.
    Wu KY; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):109-14. PubMed ID: 18289149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acupuncture on the symptoms of anxiety and depression caused by premenstrual dysphoric disorder.
    Carvalho F; Weires K; Ebling M; Padilha Mde S; Ferrão YA; Vercelino R
    Acupunct Med; 2013 Dec; 31(4):358-63. PubMed ID: 24029029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
    Pearlstein TB; Bachmann GA; Zacur HA; Yonkers KA
    Contraception; 2005 Dec; 72(6):414-21. PubMed ID: 16307962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW; Sondheimer SJ; Rickels K
    Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of premenstrual dysphoric disorder: an update.
    Steiner M; Born L
    Int Clin Psychopharmacol; 2000 Nov; 15 Suppl 3():S5-17. PubMed ID: 11195269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red cell aplasia in a prostate cancer patient treated with leuprolide acetate and chlormadinone acetate.
    Kobayashi M; Nukui A; Morita T
    Int J Urol; 2005 Nov; 12(11):1010-1. PubMed ID: 16351663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premenstrual dysphoric disorder--review of actual findings about mental disorders related to menstrual cycle and possibilities of their therapy.
    Zukov I; Ptácek R; Raboch J; Domluvilová D; Kuzelová H; Fischer S; Kozelek P
    Prague Med Rep; 2010; 111(1):12-24. PubMed ID: 20359434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Premenstrual dysphoric disorder: diagnosis and therapeutic strategy].
    Bianchi-Demicheli F
    Rev Med Suisse; 2006 Feb; 2(52):393-4, 397-9. PubMed ID: 16523546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.